ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981

Conte Withdraws Amendments Adding $40 Million for Flood Promise To Compromise

June 24, 1977

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

How Much Is Life Worth? The $440 Billion Question

July 31, 2009